Fetal Monitoring Market: Current Analysis and Forecast (2021-2027)

A diagnostic tool used to monitor the movement and heart rate of the fetus and maternal contractions is known as a fetal monitoring system. It is a fundamental device that is used for monitoring uterine contractions during labor. It mainly monitors well-being of the fetus and progress of labor. In medical terms, it is referred to as a medical method to check the health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, and jaundice. During labor and in pregnancy, the doctor checks the heartbeat of the baby to monitor the health of the unborn fetus. It is a very common procedure adopted by healthcare providers during labor and pregnancy. There are two ways to do the monitoring. First is the external monitoring that requires a special tool called fetoscope that uses sound waves and computers. The second way of monitoring is internal monitoring that requires putting a small electrode on the baby’s head while he or she is in a female uterus.
The growth of this market is driven owing to the escalating prevalence of preterm births, favorable government policies, advanced technologies of fetal monitoring systems, and active product launches. For instance, according to World Health Organization, stated in 2018, approximately 15 million preterm babies are born each year (before 37 weeks of gestation), which is more than 1 out of 10 infants and this number is increasing per year. In 184 nations, preterm birth rates vary from 5% to 18% of infants born. Increase in preterm birth worldwide is one of the major factors in driving the market. Also, the development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are anticipated to offer an opportunity for the growth of the market during the forecast period.
Based on product, the global Fetal Monitoring Market is segmented into ultrasound devices, electronic maternal/fetal monitors, uterine contraction monitors, fetal electrodes, fetal doppler devices, accessories and consumables and others. Currently, ultrasound devices segment is expected to dominate the market by holding largest market share during the forecast period. Increasing congenital anomalies, maternal mortality, along with rising regulatory approvals are certain factors which are contributing to the growth of this segment.
By portability, the global Fetal Monitoring Market is segmented into non-portable systems and portable systems. Non-portable systems segment is dominating the market. Wide applications in hospitals and diagnostic centers to assess fetal and maternal health is the the key factor responsible for the dominance of this segment in year 2020.
In terms of method, the market is categorized into invasive and noninvasive. In 2020, the noninvasive segment held the largest market share in 2020 as these methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies. Additionally, rising approvals of various noninvasive monitoring devices coupled with coming advanced technologies are further anticipated to bolster the growth of this segment.
In terms of application, the market is bifurcated into antepartum and intrapartum. Among them, the antepartum segment is forecasted to lead the market share during the forecast period. This can be ascribed to the extensive monitoring regimes, recent product launches, surging prevalence of fetal anomalies, and maternal mortalities.
Based on end-user the market is categorized into hospitals, obstetrics & gynecology clinics, and home care settings. At present, hospital segment dominates the market and is expected to maintain its dominance during the analyzed period as well. This supremacy is ascribed can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America has dominated the Fetal Monitoring Market which is attributable to the presence of a highly developed healthcare system, the increasing number of healthcare settings, technological advancements, rising patient awareness levels, and better reimbursement policies.
Moreover, Asia Pacific region is anticipated to witness highest growth over the next 5 years this can be attributed to factors such as continuous development of healthcare infrastructure in countries such as China, South Korea, and Japan, as well as rising per capita income and favorable government initiatives aimed at improving healthcare services.
Some of the major players operating in the market include Cardinal Health, Inc., Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, FUJIFILM SonoSite, Inc., Natus Medical Incorporated, Huntleigh Healthcare Limited, The Cooper Companies Inc., CONTEC Medical Systems Co., Ltd., EDAN Diagnostics, Inc.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
UMI-19159816

16-Sep-2021

172
License